Biotech start-up Normunity, Inc. has exited stealth with a $65 million Series A to create a new class of medicines that target novel I-O mechanisms, which free the body’s normal immunity against ...
ORANGE CITY, Iowa — While the rain may have made it more difficult to do certain things on the softball field on Thursday, it didn't seem to bother Addyson De Boom.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results